CYP2D6 genotype affects outcome in postmenopausal breast cancer patients treated with tamoxifen monotherapy

被引：0

作者：

Thompson, A. M. ^{[1
]}

Bray, S. ^{[1
]}

Johnson, A. M. ^{[2
]}

Quinlan, P. ^{[1
]}

Nikloff, D. M. ^{[2
]}

Evans, D. G. ^{[3
]}

Clarke, R. ^{[4
]}

Lawrence, H. J. ^{[2
]}

Howell, A. ^{[4
]}

Latif, A. ^{[3
]}

Ferraldeschl, R. ^{[3
]}

Hillman, G. ^{[2
]}

Fontecha, M. ^{[2
]}

Newman, W. G. ^{[3
]}

机构：

[1] Univ Dundee, Ninewells Hosp, Dundee DD1 4HN, Scotland

[2] Roche Mol Syst, Pleasanton, CA USA

[3] Univ Manchester, St Marys Hosp, Manchester M13 9PL, Lancs, England

[4] Univ Manchester, Paterson Inst Canc Res, Manchester M13 9PL, Lancs, England

来源：

关键词：

Breast Cancer; Tamoxifen; Postmenopausal Breast Cancer; CYP2D6 Genotype; Functional Allele;

D O I：

10.1186/bcr2545

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S15 / S15

页数：1